Tempest Therapeutics (TPST) Short Interest Ratio & Short Volume $0.90 +0.03 (+3.45%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Tempest Therapeutics Short Interest DataTempest Therapeutics (TPST) has a short interest of 2.64 million shares, representing 11.82% of the float (the number of shares available for trading by the public). This marks a -29.03% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 3.18 million shares to cover all short positions.Current Short Interest2,640,000 sharesPrevious Short Interest3,720,000 sharesChange Vs. Previous Month-29.03%Dollar Volume Sold Short$2.42 millionShort Interest Ratio0.5 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares25,210,000 sharesFloat Size22,330,000 sharesShort Percent of Float11.82%Today's Trading Volume1,038,313 sharesAverage Trading Volume3,183,680 sharesToday's Volume Vs. Average33% Short Selling Tempest Therapeutics? Sign up to receive the latest short interest report for Tempest Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTPST Short Interest Over TimeTPST Days to Cover Over TimeTPST Percentage of Float Shorted Over Time Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Tempest Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20242,640,000 shares $2.42 million -29.0%11.8%0.5 $0.92 10/15/20243,720,000 shares $4.35 million +100.0%17.6%0.9 $1.17 9/30/20241,860,000 shares $2.60 million -3.1%8.8%0.8 $1.40 9/15/20241,920,000 shares $2.78 million -6.3%9.1%0.8 $1.45 8/31/20242,050,000 shares $2.64 million -2.8%9.9%0.7 $1.29 8/15/20242,110,000 shares $3.27 million +4.5%10.2%0.7 $1.55 Get the Latest News and Ratings for TPST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20242,020,000 shares $3.60 million +4.1%11.6%2 $1.78 7/15/20241,940,000 shares $4.31 million +3.2%11.1%2 $2.22 6/30/20241,880,000 shares $4.12 million +16.8%10.8%2 $2.19 6/15/20241,610,000 shares $4.67 million -1.8%9.2%1.2 $2.90 5/31/20241,640,000 shares $5.44 million -2.4%9.4%2 $3.32 5/15/20241,680,000 shares $5.68 million +6.3%9.6%2 $3.38 4/30/20241,580,000 shares $5.48 million +39.8%9.4%1.8 $3.47 4/15/20241,130,000 shares $3.77 million +16.5%6.7%1.2 $3.34 3/31/2024969,700 shares $3.79 million +26.5%6.1%0.9 $3.91 3/15/2024766,800 shares $2.79 million +7.0%4.2%1 $3.64 2/29/2024716,500 shares $2.66 million -17.7%4.5%0.8 $3.71 2/15/2024870,400 shares $3.46 million +14.5%5.4%0.8 $3.98 1/31/2024759,900 shares $2.88 million +37.1%5.6%0.4 $3.79 1/15/2024554,300 shares $2.34 million +19.6%4.1%0.2 $4.23 12/31/2023463,400 shares $2.04 million -44.8%3.4%0 $4.40 12/15/2023838,900 shares $3.45 million +31.4%6.2%0.1 $4.11 11/30/2023638,600 shares $2.24 million -54.1%5.8%0.1 $3.52 11/15/20231,390,000 shares $4.59 million -0.7%12.5%0.1 $3.30 10/31/20231,400,000 shares $5.74 million -36.1%18.2%0.1 $4.10 10/15/20232,190,000 shares $7.97 million +7,200.0%28.5%0.3 $3.64 9/30/202330,000 shares $9,141.00 -64.7%0.4%0.1 $0.30 9/15/202385,000 shares $41,378.00 +161.5%1.1%0.6 $0.49 8/31/202332,500 shares $17,485.00 +128.9%0.5%0.3 $0.54 8/15/202314,200 shares $9,315.20 -58.6%0.2%0.1 $0.66 7/31/202334,300 shares $33,271.00 -15.9%0.6%0.4 $0.97 7/15/202340,800 shares $47,532.00 +58.1%0.7%0.2 $1.17 6/30/202325,800 shares $32,766.00 -39.3%0.5%0.1 $1.27 6/15/202342,500 shares $60,350.00 +6.5%0.7%0.2 $1.42 5/31/202339,900 shares $61,047.00 -48.8%0.8%0.2 $1.53 5/15/202377,900 shares $169,822.00 +144.2%1.5%0.3 $2.18 4/30/202331,900 shares $67,628.00 -3.3%0.8%0.1 $2.12 4/15/202333,000 shares $97,350.00 -29.9%0.8%1.1 $2.95 3/31/202347,100 shares $109,272.00 +262.3%1.1%1.8 $2.32 3/15/202313,000 shares $16,380.00 -21.2%0.3%0.8 $1.26When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! 2/28/202316,500 shares $29,040.00 +17.9%0.4%1 $1.76 2/15/202314,000 shares $24,360.00 -21.4%0.3%0.9 $1.74 1/31/202317,800 shares $35,422.00 -41.3%0.3%1.1 $1.99 1/15/202330,300 shares $52,419.00 +31.7%0.7%1.9 $1.73 12/30/202223,000 shares $26,450.00 +33.7%0.5%1.6 $1.15 12/15/202217,200 shares $24,768.00 -12.2%0.4%1.9 $1.44 11/30/202219,600 shares $31,322.76 +22.5%0.4%1.2 $1.60 11/15/202216,000 shares $26,400.00 -20.8%0.4%0.8 $1.65 10/31/202220,200 shares $37,370.00 +3.1%0.4%0.8 $1.85 10/15/202219,600 shares $31,164.00 -9.7%0.4%0.7 $1.59 9/30/202221,700 shares $37,758.00 -10.0%0.5%0.8 $1.74 9/15/202224,100 shares $56,876.00 +28.2%0.5%0.8 $2.36 8/31/202218,800 shares $40,608.00 -68.4%0.4%0.7 $2.16 8/15/202259,400 shares $147,906.00 -39.6%1.3%1.3 $2.49 7/31/202298,400 shares $199,752.00 -20.6%2.2%1.6 $2.03 7/15/2022123,900 shares $314,706.00 -7.3%2.8%0.4 $2.54 6/30/2022133,600 shares $287,240.00 -23.6%3.0%0.4 $2.15 6/15/2022174,900 shares $372,537.00 -24.5%3.9%0.5 $2.13 5/31/2022231,700 shares $667,296.00 +23.2%12.4%0.7 $2.88 5/15/2022188,000 shares $541,440.00 -59.0%14.5%0.6 $2.88 4/30/2022458,800 shares $1.66 million +1,835.9%14.5%1.6 $3.61 4/15/202223,700 shares $80,817.00 +22.8%0.8%0.7 $3.41 3/31/202219,300 shares $65,234.00 +1.1%0.6%0.6 $3.38 3/15/202219,100 shares $44,121.00 -19.4%0.6%0.6 $2.31 2/28/202223,700 shares $77,262.00 +2.2%0.8%0.7 $3.26 2/15/202223,200 shares $80,504.00 -12.5%0.7%0.8 $3.47 1/31/202226,500 shares $105,205.00 -18.0%0.5%0.9 $3.97 1/15/202232,300 shares $132,753.00 -0.6%0.6%1.1 $4.11 12/31/202132,500 shares $171,600.00 +8.7%0.6%1.2 $5.28 12/15/202129,900 shares $210,795.00 -19.2%0.6%1.7 $7.05 11/30/202137,000 shares $366,300.00 -19.9%0.7%1.6 $9.90 11/15/202146,200 shares $509,586.00 -16.3%0.9%1.5 $11.03 10/29/202155,200 shares $646,944.00 -2.8%1.1%1.1 $11.72 10/15/202156,800 shares $833,824.00 -30.7%1.1%0.5 $14.68 9/30/202182,000 shares $1.19 million +0.7%1.7%0.2 $14.47 9/15/202181,400 shares $1.26 million +93.4%1.6%0.1 $15.44 8/31/202142,100 shares $606,661.00 -56.1%0.9%0.1 $14.41 8/13/202195,900 shares $1.28 million No ChangeN/A0.1 $13.30 6/15/20212,420,000 shares $3.48 million +22.2%15.1%1.1 $1.44 5/28/20211,980,000 shares $2.36 million +28.6%12.3%1.2 $1.19 5/14/20211,540,000 shares $1.48 million +31.6%N/A1.1 $0.96 4/30/20211,170,000 shares $1.33 million +3.5%N/A1 $1.14 4/15/20211,130,000 shares $1.22 million +123.1%N/A1.3 $1.08 3/31/2021506,400 shares $648,192.00 +62.5%N/A0.6 $1.28 3/15/2021311,600 shares $663,708.00 -0.5%N/A0.5 $2.13 2/26/2021313,000 shares $694,860.00 -28.3%N/A0.5 $2.22 2/12/2021436,700 shares $1.14 million -33.0%N/A0.7 $2.62 1/29/2021651,400 shares $1.21 million -7.3%N/A1.1 $1.86 1/15/2021702,700 shares $1.28 million +55.6%N/A1.4 $1.82 12/31/2020451,600 shares $961,908.00 +11.9%N/A1 $2.13When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! 12/15/2020403,500 shares $786,825.00 -26.6%N/A1 $1.95 11/30/2020549,700 shares $1.03 million -13.5%N/A1.6 $1.88 11/15/2020635,800 shares $979,132.00 +36.2%N/A1.8 $1.54 10/30/2020466,800 shares $690,864.00 -51.2%N/A1.3 $1.48 10/15/2020955,500 shares $1.61 million +39.2%N/A2.3 $1.69 9/30/2020686,400 shares $1.12 million +25.9%N/A1.2 $1.63 9/15/2020545,100 shares $877,611.00 +38.5%N/A0.9 $1.61 8/31/2020393,500 shares $712,235.00 -22.8%N/A0.3 $1.81 8/14/2020509,700 shares $942,945.00 -39.1%N/A0.4 $1.85 7/31/2020836,500 shares $1.45 million -6.5%N/A0.6 $1.73 7/15/2020894,800 shares $1.52 million -10.5%N/A0.6 $1.70 6/30/20201,000,000 shares $1.76 million +32.4%7.5%0.6 $1.76 6/15/2020755,100 shares $1.53 million +34.6%5.7%0.5 $2.02 5/29/2020561,100 shares $1.49 million +5.9%4.2%0.5 $2.66 5/15/2020529,800 shares $863,574.00 +19.9%4.0%0.6 $1.63 4/30/2020442,000 shares $738,140.00 +43.6%3.4%0.6 $1.67 4/15/2020307,900 shares $489,561.00 +6.3%2.8%0.6 $1.59 3/31/2020289,700 shares $434,550.00 +8.8%2.8%1 $1.50 3/13/2020266,300 shares $378,146.00 +67.5%2.7%1.2 $1.42 2/28/2020159,000 shares $1.03 million -16.9%1.6%1.4 $6.45 2/14/2020191,400 shares $1.29 million +31.4%1.9%2.1 $6.72 1/31/2020145,700 shares $1.26 million +5.7%1.4%2.1 $8.68 1/15/2020137,800 shares $920,504.00 +9.7%1.3%2.2 $6.68 12/31/2019125,600 shares $1.04 million +20.0%1.2%2.3 $8.28 TPST Short Interest - Frequently Asked Questions What is Tempest Therapeutics' current short interest? Short interest is the volume of Tempest Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 2,640,000 shares of TPST short. 11.82% of Tempest Therapeutics' shares are currently sold short. Learn More on Tempest Therapeutics' current short interest. What is a good short interest percentage for Tempest Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.82% of Tempest Therapeutics' floating shares are currently sold short. Is Tempest Therapeutics' short interest increasing or decreasing? Tempest Therapeutics saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 2,640,000 shares, a decrease of 29.0% from the previous total of 3,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tempest Therapeutics' float size? Tempest Therapeutics currently has issued a total of 25,210,000 shares. Some of Tempest Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tempest Therapeutics currently has a public float of 22,330,000 shares. How does Tempest Therapeutics' short interest compare to its competitors? 11.82% of Tempest Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tempest Therapeutics: Generation Bio Co. (3.40%), Annovis Bio, Inc. (10.15%), PowerUp Acquisition Corp. (0.06%), SELLAS Life Sciences Group, Inc. (12.23%), Relmada Therapeutics, Inc. (3.94%), Genenta Science S.p.A. (0.03%), Genelux Co. (5.15%), Ikena Oncology, Inc. (0.44%), PMV Pharmaceuticals, Inc. (1.94%), Quince Therapeutics, Inc. (7.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Tempest Therapeutics stock? Short selling TPST is an investing strategy that aims to generate trading profit from Tempest Therapeutics as its price is falling. TPST shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tempest Therapeutics? A short squeeze for Tempest Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TPST, which in turn drives the price of the stock up even further. How often is Tempest Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TPST, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Genelux Short Interest 23andMe Short Interest CASI Pharmaceuticals Short Interest FibroBiologics Short Interest PMV Pharmaceuticals Short Interest Oncolytics Biotech Short Interest Ikena Oncology Short Interest Quince Therapeutics Short Interest Clearside Biomedical Short Interest Chimerix Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TPST) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TPST Stock Alerts